Add BrightSurf on Google Email

Diet designed to lower blood pressure also reduces risk of kidney disease

A study published in American Journal of Kidney Diseases found that following a DASH-style diet can lower the risk of developing chronic kidney disease over two decades. The diet, which emphasizes whole grains, fruits, vegetables, and low-fat dairy, was also shown to reduce blood pressure and cardiovascular disease risk.

SourceJohns Hopkins Bloomberg School of Public Health·JournalAmerican Journal of Kidney Diseases·DateAug 9, 2016

Simple public health intervention may prevent chronic kidney disease

A simple public health intervention helped prevent many cases of chronic kidney disease (CKD) in Pakistan by training community health workers and general practitioners on healthy lifestyle advice. After 7 years, individuals with the combined intervention had preserved kidney function, while those who received usual care experienced a ...

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateMay 19, 2016

Kidney disease may increase hospitalized patients' risk of complications

Patients with chronic kidney disease (CKD) are at a higher risk of experiencing hospital-acquired complications when hospitalized. A study of 536,549 adults found that CKD patients were 19% more likely to experience complications than those with normal kidney function, with the risk increasing as CKD severity worsened.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateMay 12, 2016

Climate change may contribute to rising rates of chronic kidney disease

Research suggests that climate change and resulting water shortages are linked to an increase in chronic kidney disease caused by dehydration and heat stress. The study found that rural hot communities are disproportionately affected, with risks increasing for cognitive dysfunction, malnutrition, and other conditions.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateMay 5, 2016

ACP publishes depression recommendations; news from Annals of Internal Medicine

The American College of Physicians recommends using either cognitive behavioral therapy or second-generation antidepressants to treat adults with major depressive disorder. Both treatments are found to be similarly effective for treating depression, and physicians should consider a discussion with the patient about treatment effects, a...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateFeb 8, 2016

Mitochondrial DNA levels in the blood may predict risk of developing kidney disease

A study found that high levels of mitochondrial DNA in the blood are associated with a lower risk of developing chronic kidney disease (CKD). The researchers analyzed data from over 9,500 participants and discovered that individuals with higher mitochondrial DNA copy numbers had a 25% lower risk of CKD compared to those with lower levels.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateJan 21, 2016

Researchers find key player in diabetic kidney disease through power of metabolomics

A new study by University of California, San Diego researchers has identified a pivotal player in diabetic kidney disease and a potential biomarker for diagnosing and monitoring chronic kidney disease. The study uses metabolomics analysis to clarify a central mechanism of action involving the NADPH oxidase proteins NOX1 and NOX4.

SourceUniversity of California - San Diego·JournalJournal of the American Society of Nephrology·DateJul 22, 2015

More dialysis patients living in poor neighborhoods

A recent study published in Hemodialysis International found that the association between poverty and kidney disease changes over time. Adults beginning dialysis are more likely to be living in a poor zip code, with rates increasing from 27.4% in 1995-2004 to 34% in 2005-2010.

SourceLoyola Medicine·JournalHemodialysis International·DateJun 15, 2015

New treatment for polycystic kidney disease

Researchers have discovered a new treatment approach targeting tiny blood and lymphatic vessels inside the kidneys, which improves renal function and slows disease progression in mice. This innovative therapy may offer hope for patients with polycystic kidney disease, particularly those with rare forms of the condition.

SourceUniversity of Manchester·JournalJournal of the American Society of Nephrology·DateJun 3, 2015

The Lancet Diabetes & Endocrinology: 2015 ERA-EDTA Congress media alert

A collaborative meta-analysis found that creatinine-based eGFR and albuminuria improve cardiovascular prediction, particularly for mortality and heart failure. The assessment of albumin-to-creatinine ratio (ACR) outperformed traditional risk factors, suggesting its potential broad implications for cardiovascular risk classification.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateMay 29, 2015